HPR110 ESG in Pharma Procurement, Not More Than Wishful Thinking? A Quantitative View on Award Criteria in Tenders in the EU5 From 2011 to 2020
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1240
https://www.valueinhealthjournal.com/article/S1098-3015(22)03445-3/fulltext
Title :
HPR110 ESG in Pharma Procurement, Not More Than Wishful Thinking? A Quantitative View on Award Criteria in Tenders in the EU5 From 2011 to 2020
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03445-3&doi=10.1016/j.jval.2022.09.1240
First page :
Section Title :
Open access? :
No
Section Order :
10790